簡介

本頁面提供了有關 Mark W Hahn 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Mark W Hahn已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:SLNO / Soleno Therapeutics, Inc. Director 0
US:VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) Chief Financial Officer 0
US:ALOR / ALSP Orchid Acquisition Corp I - Class A Director 0
US:DOVA / Dova Pharmaceuticals, Inc. Chief Financial Officer 0
US:CEMP / Cempra, Inc. EVP and CFO 25,000
如何解讀這些圖表

以下圖表顯示了在Mark W Hahn進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Mark W Hahn 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-05-18 2026-05-18 4 SLNO SOLENO THERAPEUTICS INC
Common Stock
D - Sale to Issuer -10,046 0 -100.00
2025-10-14 2025-10-13 4 SLNO SOLENO THERAPEUTICS INC
Common Stock
A - Award 10,046 10,046
2025-10-08 2025-10-07 4 VRNA Verona Pharma plc
Ordinary Shares
D - Sale to Issuer -3,285,280 0 -100.00
2025-10-08 2025-10-07 4 VRNA Verona Pharma plc
Ordinary Shares
M - Exercise 3,285,280 3,285,280
2025-10-08 2025-10-07 4 VRNA Verona Pharma plc
Ordinary Shares
D - Sale to Issuer -11,264,968 0 -100.00
2025-09-03 2025-08-29 4 VRNA Verona Pharma plc
Ordinary Shares
G - Gift -1,200,000 11,264,968 -9.63
2025-08-05 2025-08-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -208,912 12,464,968 -1.65 13.14 -2,745,877 163,835,800
2025-08-05 2025-08-01 4 VRNA Verona Pharma plc
Ordinary Shares
M - Exercise 255,696 12,673,880 2.06
2025-07-09 2025-07-08 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -90,320 12,418,184 -0.72 11.44 -1,033,378 142,080,169
2025-07-09 2025-07-07 4 VRNA Verona Pharma plc
Ordinary Shares
M - Exercise 229,512 12,508,504 1.87
2025-06-13 2025-06-11 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -400,000 12,278,992 -3.15 11.40 -4,560,360 139,991,560
2025-05-29 2025-05-29 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -204,864 12,678,992 -1.59 9.33 -1,911,668 118,312,746
2025-05-29 2025-05-28 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -162,704 12,883,856 -1.25 9.30 -1,513,294 119,831,456
2025-05-29 2025-05-27 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -32,432 13,046,560 -0.25 9.53 -308,983 124,295,882
2025-05-05 2025-05-02 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -400,000 13,078,992 -2.97 9.09 -3,637,720 118,944,277
2025-05-05 2025-05-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -78,736 13,478,992 -0.58 8.95 -704,703 120,639,674
2025-05-05 2025-05-01 4 VRNA Verona Pharma plc
Ordinary Shares
M - Exercise 200,000 13,557,728 1.50
2025-05-05 2025-05-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -108,272 13,357,728 -0.80 8.95 -969,056 119,554,337
2025-05-01 2025-04-29 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -90,360 13,466,000 -0.67 8.98 -811,433 120,924,680
2025-05-01 2025-04-29 4 VRNA Verona Pharma plc
Ordinary Shares
M - Exercise 229,512 13,556,360 1.72
2025-02-04 2025-02-03 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -166,888 13,326,848 -1.24 7.16 -1,195,335 95,453,549
2025-02-04 2025-02-01 4 VRNA Verona Pharma plc
Ordinary Shares
A - Award 200,000 13,493,736 1.50
2024-12-06 2024-12-06 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -183,728 13,293,736 -1.36 5.01 -920,312 66,589,653
2024-12-06 2024-12-05 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -640,048 13,477,464 -4.53 5.01 -3,204,144 67,469,533
2024-12-06 2024-12-04 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -58,184 14,117,512 -0.41 5.00 -290,996 70,605,913
2024-12-02 2024-12-02 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -1,600 14,175,696 -0.01 5.00 -8,000 70,878,480
2024-12-02 2024-11-29 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -98,704 14,177,296 -0.69 5.01 -494,142 70,975,797
2024-12-02 2024-11-27 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -12,936 14,276,000 -0.09 5.00 -64,680 71,380,000
2024-11-26 2024-11-26 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -800 14,288,936 -0.01 5.00 -4,000 71,444,680
2024-11-26 2024-11-25 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -1,600 14,289,736 -0.01 5.00 -8,000 71,448,680
2024-11-13 2024-11-11 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -2,400 14,291,336 -0.02 5.00 -12,000 71,456,680
2024-11-05 2024-11-04 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -80,784 14,293,736 -0.56 4.39 -354,448 62,715,196
2024-11-05 2024-11-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -48,888 14,374,520 -0.34 4.38 -213,939 62,904,337
2024-11-01 2024-11-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -245,952 14,423,408 -1.68 4.24 -1,043,132 61,172,558
2024-11-01 2024-11-01 4 VRNA Verona Pharma plc
Ordinary Shares
A - Award 200,000 14,669,360 1.38
2024-11-01 2024-10-30 4 VRNA Verona Pharma plc
Ordinary Shares
A - Award 800,000 14,469,360 5.85
2024-10-25 2024-10-25 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -3,200 13,669,360 -0.02 4.38 -14,000 59,803,450
2024-10-25 2024-10-24 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -141,360 13,672,560 -1.02 4.38 -618,761 59,847,530
2024-10-22 2024-10-22 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -159,344 13,813,920 -1.14 4.38 -698,708 60,572,658
2024-10-22 2024-10-21 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -116,696 13,973,264 -0.83 4.38 -511,082 61,197,307
2024-10-22 2024-10-18 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -249,728 14,089,960 -1.74 4.38 -1,093,983 61,723,888
2024-09-13 2024-09-11 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -600,000 14,339,688 -4.02 3.76 -2,254,080 53,871,340
2024-08-14 2024-08-13 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -3,736 14,939,688 -0.03 3.25 -12,142 48,553,986
2024-08-14 2024-08-13 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -394,664 14,943,424 -2.57 3.20 -1,263,398 47,836,889
2024-08-14 2024-08-12 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -1,600 15,338,088 -0.01 3.13 -5,008 48,008,215
2024-08-09 2024-08-07 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -314,800 15,339,688 -2.01 2.62 -824,776 40,189,983
2024-08-09 2024-08-07 4 VRNA Verona Pharma plc
Ordinary Shares
A - Award 800,000 15,654,488 5.39
2024-08-05 2024-08-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -88,544 14,854,488 -0.59 2.83 -250,801 42,075,337
2024-05-03 2024-05-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -88,544 14,943,032 -0.59 1.93 -171,005 28,859,478
2024-02-05 2024-02-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -480,664 15,031,576 -3.10 2.29 -1,102,547 34,479,429
2023-11-03 2023-11-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -809,008 15,512,240 -4.96 1.74 -1,410,748 27,050,244
2023-10-24 2023-10-20 4 VRNA Verona Pharma plc
Ordinary Shares
A - Award 800,000 16,321,248 5.15
2023-08-07 2023-08-07 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -8,616 15,521,248 -0.06 2.47 -21,263 38,304,888
2023-08-07 2023-08-04 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -150,000 15,529,864 -0.96 2.50 -374,880 38,812,236
2023-08-07 2023-08-03 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -117,272 15,679,864 -0.74 2.54 -297,754 39,811,175
2023-08-03 2023-08-02 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -73,704 15,797,136 -0.46 2.59 -191,114 40,961,974
2023-08-03 2023-08-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -105,944 15,870,840 -0.66 2.68 -283,824 42,517,980
2023-05-03 2023-05-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -455,528 15,976,784 -2.77 2.58 -1,173,395 41,154,598
2023-02-03 2023-02-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -413,168 16,432,312 -2.45 2.56 -1,056,553 42,020,708
2022-12-21 2022-12-20 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -600,000 16,845,480 -3.44 2.12 -1,269,060 35,629,875
2022-11-03 2022-11-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -13,160 17,445,480 -0.08 1.67 -22,011 29,179,310
2022-11-03 2022-11-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -454,856 17,458,640 -2.54 1.60 -727,770 27,933,824
2022-09-28 2022-09-26 4 VRNA Verona Pharma plc
Ordinary Shares
A - Award 3,600,000 17,913,496 25.15
2022-08-11 2022-08-09 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -600,000 14,313,496 -4.02 1.75 -1,050,000 25,048,618
2022-08-03 2022-08-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -13,168 14,913,496 -0.09 0.70 -9,215 10,436,465
2022-08-03 2022-08-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -454,856 14,926,664 -2.96 0.67 -305,891 10,038,182
2022-05-05 2022-05-03 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -12,512 15,381,520 -0.08 0.50 -6,201 7,623,081
2022-05-03 2022-05-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -432,128 15,394,032 -2.73 0.52 -225,787 8,043,382
2022-02-03 2022-02-02 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -10,416 15,826,160 -0.07 0.76 -7,877 11,967,742
2022-02-03 2022-02-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -288,320 15,836,576 -1.79 0.78 -223,794 12,292,350
2022-02-03 2022-02-01 4 VRNA Verona Pharma plc
Ordinary Shares
A - Award 133,776 16,124,896 0.84 0.75 99,998 12,053,360
2021-11-18 3 ALOR ALSP Orchid Acquisition Corp I
No securities are beneficially owned
0
2021-11-03 2021-11-02 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -10,416 15,991,120 -0.07 0.65 -6,721 10,319,070
2021-11-03 2021-11-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -454,848 16,001,536 -2.76 0.64 -291,103 10,240,983
2021-08-03 2021-08-02 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -10,416 16,456,384 -0.06 0.77 -7,989 12,622,047
2021-08-03 2021-08-01 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -454,840 16,466,800 -2.69 0.78 -357,049 12,926,438
2021-05-05 2021-05-03 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -10,416 16,921,640 -0.06 0.87 -9,094 14,774,284
2021-05-05 2021-05-03 4 VRNA Verona Pharma plc
Ordinary Shares
F - Taxes -2,122,448 16,932,056 -11.14 0.89 -1,883,673 15,027,200
2021-03-03 2021-03-01 4 VRNA Verona Pharma plc
Ordinary Shares
S - Sale X -26,728 19,054,504 -0.14 1.14 -30,571 21,794,542
2021-02-01 2021-01-28 4 VRNA Verona Pharma plc
Ordinary Shares
A - Award 105,824 19,081,232 0.56
2021-01-04 3 VRNA Verona Pharma plc
Ordinary Shares
18,975,408
2019-11-12 2019-11-12 4 DOVA Dova Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -250,000 0 -100.00
2019-11-12 2019-11-12 4 DOVA Dova Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -50,000 0 -100.00
2019-11-12 2019-11-12 4 DOVA Dova Pharmaceuticals Inc.
Common Stock
D - Sale to Issuer -9,024 0 -100.00
2019-10-02 2019-09-30 4 DOVA Dova Pharmaceuticals Inc.
Common Stock
S - Sale X -775 9,024 -7.91 28.00 -21,700 252,672
2019-07-02 2019-07-01 4 DOVA Dova Pharmaceuticals Inc.
Common Stock
S - Sale X -1,545 9,799 -13.62 14.17 -21,893 138,852
2019-01-08 2019-01-04 4 DOVA Dova Pharmaceuticals Inc.
Employee Stock Option (right to buy)
A - Award 250,000 250,000
2019-01-08 2019-01-04 4 DOVA Dova Pharmaceuticals Inc.
Common Stock
A - Award 8,844 11,344 353.76
2018-12-21 2018-12-19 4 DOVA Dova Pharmaceuticals Inc.
Common Stock
P - Purchase 2,500 2,500 6.28 15,700 15,700
2018-10-10 2018-10-08 4 DOVA Dova Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 50,000 50,000
2018-02-01 2018-01-31 4 DOVA Dova Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
A - Award 175,000 175,000
2018-02-01 3 DOVA Dova Pharmaceuticals, Inc.
Common Stock
0
2017-02-27 2017-02-23 4 CEMP CEMPRA, INC.
Employee Stock Option (Right to Buy)
A - Award 25,000 25,000
2017-02-27 2017-02-23 4 CEMP CEMPRA, INC.
Restricted Stock Units
A - Award 25,000 25,000
2017-01-05 2017-01-03 4 CEMP CEMPRA, INC.
Restricted Stock Units
A - Award 50,000 50,000
2017-01-05 2017-01-03 4 CEMP CEMPRA, INC.
Employee Stock Option (Right to Buy)
A - Award 125,000 125,000
2016-01-05 2016-01-01 4 CEMP CEMPRA, INC.
Employee Stock Option (Right to Buy)
A - Award 59,660 59,660
2015-01-02 2015-01-01 4 CEMP CEMPRA, INC.
Employee Stock Option (Right to Buy)
A - Award 46,363 46,363
2014-01-10 2014-01-08 4 CEMP CEMPRA, INC.
Employee Stock Option (Right to Buy)
A - Award 45,000 45,000
2014-01-10 2014-01-08 4 CEMP CEMPRA, INC.
Employee Stock Option (Right to Buy)
A - Award 15,000 15,000
2013-01-22 2013-01-18 4 CEMP CEMPRA, INC.
Employee Stock Option (Right to Buy)
A - Award 50,000 50,000
2012-03-22 2012-03-20 4 CEMP CEMPRA, INC.
Employee Stock Option (Right to Buy)
A - Award 25,000 25,000
2012-02-03 3 CEMP Cempra Holdings, LLC
None
0
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)